Skip to content

Optimizing the Evaluation of Awareness in Disorders of Consciousness

Using High-resolution Electroencephalography to Optimize the Evaluation of Awareness in Patients With Disorders of Consciousness

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02628639
Acronym
CONPHIDENSE
Enrollment
28
Registered
2015-12-11
Start date
2016-01-31
Completion date
Unknown
Last updated
2015-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders of Consciousness

Brief summary

The purpose of this study is to evaluate whether personalized stimulations can improve the detection of electrophysiological signs of awareness in patients with disorders of consciousness.

Interventions

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients in a vegetative state or a minimally conscious state * agreement from families

Exclusion criteria

* patients with akinetic mutism or locked-in syndrome * patients in a coma * patients with damages in the inner or middle ear * contraindication to a high-density electroencephalography exam

Design outcomes

Primary

MeasureTime frameDescription
Number of participants showing differences of electrophysiological activity after personalized but not standard stimulation protocolsstandard stimulations: 28 days after recruiting patientsDepending of the personalized stimulation protocol, the differences of electrophysiological activity can the presence of event-related potentials (N100, mismatch negativity, P300, etc.) or alterations of neural oscillations. The personalized stimulation protocol will be chosen according to the families' feeling of a presence.

Contacts

Primary ContactDamien Gabriel, PhD
dgabriel@chu-besancon.fr381219148

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026